{"disease":{"id":"impotence","name":"Impotence","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":10,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"tadalafil","indication_name":"Impotence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cialis","generic_name":"tadalafil","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Nuclear receptor subfamily 2 group E member 1, Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Potassium voltage-gated channel subfamily H member 2","drug_class":"Phosphodiesterase 5 Inhibitor [EPC]","quality_score":23,"revenue":null,"mechanism":null},{"drug_id":"avanafil","indication_name":"Impotence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Stendra","generic_name":"AVANAFIL","company_name":"Vivus Llc","drug_phase":"marketed","molecular_target":"cGMP-specific 3',5'-cyclic phosphodiesterase","drug_class":"Phosphodiesterase 5 Inhibitor [EPC]","quality_score":50,"revenue":null,"mechanism":"Stendra works by inhibiting an enzyme that breaks down a molecule called cyclic GMP, allowing blood vessels to relax and improve blood flow to the penis."},{"drug_id":"moxisylyte","indication_name":"Impotence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Moxilite","generic_name":"MOXISYLYTE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"moxisylyte","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"alprostadil","indication_name":"Impotence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Caverject","generic_name":"ALPROSTADIL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Prostaglandin E2 receptor EP3 subtype","drug_class":"Prostaglandin Analog [EPC]","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"levitra","indication_name":"Impotence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Levitra","company_name":"Rabin Medical Center","drug_phase":"marketed","molecular_target":"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"cialis","indication_name":"Impotence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cialis","company_name":"Ottawa Hospital Research Institute","drug_phase":"marketed","molecular_target":"Nuclear receptor subfamily 2 group E member 1, Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Potassium voltage-gated channel subfamily H member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"mirodenafil","indication_name":"Impotence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mvix","generic_name":"MIRODENAFIL","company_name":"","drug_phase":"marketed","molecular_target":"cGMP-specific 3',5'-cyclic phosphodiesterase","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"revatio","indication_name":"Impotence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Revatio","generic_name":"Sildenafil Citrate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Phosphodiesterase type 5 (PDE5)","drug_class":"PDE5 inhibitor","quality_score":66,"revenue":null,"mechanism":"Sildenafil inhibits phosphodiesterase type 5 (PDE5), increasing cGMP levels and enabling penile smooth muscle relaxation."},{"drug_id":"prostavasin","indication_name":"Impotence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Prostavasin","company_name":"Hannover Medical School","drug_phase":"phase_2","molecular_target":"Cation channel sperm-associated protein 1, Cation channel sperm-associated protein 2, Cation channel sperm-associated protein 3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"sildenafil","indication_name":"Impotence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Viagra","generic_name":"sildenafil","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, Multidrug resistance-associated protein 5","drug_class":"PDE5 inhibitor","quality_score":null,"revenue":null,"mechanism":"Selectively inhibits phosphodiesterase type 5 (PDE5), increasing cGMP levels to relax smooth muscle in the corpus cavernosum and pulmonary vasculature."}],"pipeline":[],"offLabel":[],"totalMarketed":10,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01383018","title":"PROPPER Prospective Registry of Outcomes With Penile Prosthesis","phase":"","overall_status":"COMPLETED","enrollment_count":1457,"lead_sponsor_name":"Boston Scientific Corporation","has_results":true},{"nct_id":"NCT04304742","title":"Radiologist Diagnostic Performance Versus Artificial Intelligence (AI)","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT07277673","title":"Aerobic Exercise Addition to Cognitive Behavioural Treatment in Impotence Metabolic-syndrome Drinkers","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT03830164","title":"Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true}],"total":4},"guidelines":[{"drug_id":"revatio","guideline_body":"FDA label","recommendation":"Sildenafil is indicated for the treatment of erectile dysfunction.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}